Target type: molecularfunction
Binding to a sphingolipid, a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid). [ISBN:0198506732]
Sphingolipid binding is a molecular function that involves the interaction of proteins with sphingolipids, a class of lipids that play crucial roles in various cellular processes. Sphingolipids are structurally diverse and encompass a wide range of molecules, including ceramides, sphingomyelins, and glycosphingolipids. Their diverse structures and functions make them essential components of cellular membranes, where they contribute to membrane fluidity, stability, and signaling.
The binding of proteins to sphingolipids can occur through various mechanisms, including hydrophobic interactions, hydrogen bonding, and electrostatic interactions. These interactions are often mediated by specific domains within the protein, such as the lipid-binding domain or the sphingolipid-binding domain.
The molecular function of sphingolipid binding encompasses a wide range of activities that are critical for cellular function, including:
* **Membrane organization and trafficking:** Sphingolipid binding proteins play a role in regulating the organization and trafficking of cellular membranes. By interacting with sphingolipids, these proteins can influence membrane fluidity, curvature, and the formation of membrane domains.
* **Signal transduction:** Sphingolipids are key signaling molecules that mediate a variety of cellular responses, including cell growth, differentiation, apoptosis, and inflammation. Sphingolipid binding proteins can act as receptors for sphingolipids, mediating downstream signaling pathways.
* **Cellular recognition and adhesion:** Sphingolipids can act as ligands for cell adhesion molecules, facilitating cell-cell interactions and the formation of tissues. Sphingolipid binding proteins can mediate these interactions.
* **Immune response:** Sphingolipids and their binding proteins are involved in the regulation of the immune response, including the activation and differentiation of immune cells.
The specific molecular function of a sphingolipid binding protein is often determined by the type of sphingolipid it binds to, the domain structure of the protein, and the cellular context. Dysregulation of sphingolipid binding can lead to a range of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases.
Understanding the molecular function of sphingolipid binding is crucial for developing novel therapeutic strategies for these diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sphingosine 1-phosphate receptor 1 | A sphingosine 1-phosphate receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P21453] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
fingolimod hydrochloride | fingolimod hydrochloride : The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod). Fingolimod Hydrochloride: A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS. | hydrochloride | immunosuppressive agent; prodrug; sphingosine-1-phosphate receptor agonist |
fingolimod | fingolimod : An aminodiol that consists of propane-1,3-diol having amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis. A prodrug, fingolimod is phosphorylated by sphingosine kinase to active metabolite fingolimod-phosphate, a structural analogue of sphingosine 1-phosphate. | aminodiol; primary amino compound | antineoplastic agent; CB1 receptor antagonist; immunosuppressive agent; prodrug; sphingosine-1-phosphate receptor agonist |
sew2871 | SEW2871: structure in first source | oxadiazole; ring assembly | |
sphingosine 1-phosphate | sphingosine 1-phosphate : A phosphosphingolipid that consists of sphingosine having a phospho group attached at position 1 sphingosine 1-phosphate: RN given refers to (R-(R*,S*-(E)))-isomer; RN for cpd without isomeric designation not available 8/89 | sphingoid 1-phosphate | mouse metabolite; signalling molecule; sphingosine-1-phosphate receptor agonist; T-cell proliferation inhibitor; vasodilator agent |
N-cyclohexyl-5-propyl-3-isoxazolecarboxamide | aromatic amide; heteroarene | ||
N,N-dicyclohexyl-5-propyl-3-isoxazolecarboxamide | aromatic amide; heteroarene | ||
fty 720p | fingolimod phosphate : A primary amino compound that is fingolimod in which one on the hydroxy groups has been converted into its dihydrogen phosphate derivative. It is the active metabolite of fingolimod. | monoalkyl phosphate; primary alcohol; primary amino compound | antineoplastic agent; immunosuppressive agent; sphingosine-1-phosphate receptor agonist |
jte 013 | JTE 013: an Edg-5 antagonist JTE-013 : A semicarbazide derivative that is semicarbazide in which the amino group at position 2 is replaced by a [1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]amino group and the amino group adjacent to the carbonyl is replaced by a (2,6-dichloropyridin-4-yl)amino group. It is a potent S1P2 antagonist (IC50 = 17.6 nM). | chloropyridine; pyrazolopyridine | anti-asthmatic agent; anti-inflammatory agent; antineoplastic agent; osteogenesis regulator; pro-angiogenic agent; sphingosine-1-phosphate receptor 2 antagonist |
auy 954 | AUY 954: an S1P(1) receptor agonist; structure in first source | ||
ponesimod | ponesimod: structure in first source | ||
fty 720p | |||
VPC 23019 | VPC 23019 : A secondary carboxamide resulting from the formal condensation of the carboxy group of O-phospho-D-serine with the amino group of m-octylaniline. An analogue of sphingosine-1-phosphate (S1P), it is a potent antagonist for both S1P1 and S1P3 receptors. It can inhibit S1P-induced migration of thyroid cancer cells, ovarian cancer cells, and neural stem cells. VPC23019: inhibits S1P3 receptor; structure in first source | aromatic amide; D-serine derivative; organic phosphate; phosphoric ester; secondary carboxamide | sphingosine-1-phosphate receptor 1 antagonist; sphingosine-1-phosphate receptor 3 antagonist |
gw9508 | GW9508: structure in first source | aromatic amine | |
cs-2100 | |||
cym-5442 | oxadiazole; ring assembly | ||
siponimod | siponimod: S1P receptor modulator |